Alpha One

Founder of Alpha Briefing, a high-signal intelligence and finance platform delivering sharp analysis at the intersection of markets, geopolitics, and strategy.

Paid-members only

Geopolitics Featured

Why the U.S. Navy Is Shopping for Warships in South Korea

The U.S. Navy just asked South Korean yards whether they can build its destroyers and oilers — the first crack in an 80-year ban on foreign-built warships. The stocks are pricing the order book; Congress is drafting the veto.

Markets Featured

What Happens When America Stops Drinking?

Americans' drinking rate just hit a 90-year low — and this month the decline moved from survey data to layoffs, bar closures, and multi-year stock lows. The market isn't pricing one alcohol trade. It's deciding who survives a smaller pool of drinkers.

Members only

Markets Featured

10 Stocks Worth Watching This Week: The AI Unwind Meets an Earnings Gauntlet — July 20–24, 2026

Semiconductors just shed over $1 trillion on the Kimi K3 shock, oil is back near $90 on the US–Iran war, and Alphabet, Tesla, and Intel all report within 48 hours. The 10 names that matter this week.

Finance Featured

Why Big Pharma Finally Went Psychedelic

Eli Lilly just agreed to pay up to $3.8 billion for a psychedelic drugmaker whose lead asset is synthetic toad venom — days after the FDA put the first psilocybin therapies on a fast track. The 30-year freeze in the depression drug market is breaking, and the repricing has started.

Paid-members only

Markets Featured

Top 10 Stocks to Watch — Monday, July 20

Earnings week opens with Brent above $90 and catalysts stacked at both ends of the session: steel and regional-bank prints tonight, a biotech two events from a binary readout, and the mega-cap reports that decide the AI trade. Ten names, ranked by catalyst.

Paid-members only

Markets Featured

SELLAS (SLS) Is Two Deaths From a Phase 3 Answer It Can't See Yet. Here's the Distribution.

SELLAS ran near ten-fold in a year on a pivotal AML trial that's event-driven and just two deaths from its final analysis. The balance sheet, the ~197M-share cap, and the three scenario zones before the 80th event prints.

Paid-members only

Macro Featured

America Is About to Tie Childcare to Your Job

Washington's answer to the $172 billion childcare crisis finally arrived — as a tax credit routed through employers, not public funding. The last time America did this with a benefit, it was health insurance in 1943. Here's who collects this time.

Paid-members only

Markets Featured

Nobody Told the Central Banks Gold Was Correcting

Gold has fallen 28% from its January high and retail is calling the top. The buyers who set the floor — central banks — are accumulating at record intent. The correction is an entry, not an exit.

Paid-members only

Defence Featured

Why the Defense Supercycle Has a Congress Problem

The Pentagon's $1.5 trillion budget was always two documents stapled together. On July 15, the House put a price on the second one: 17 cents on the dollar. Here's what it means for every defense thesis written this year.

Paid-members only

Finance Featured

Why $8 Trillion in Cash Isn't Coming to Save the Stock Market

Money market funds just hit a record $8.3 trillion — and the managers running them just positioned for rates to stay high. The 'cash on the sidelines' bull case has a flows problem, and the real trade is whoever tolls the pile.

Macro Featured

Is America About to Stop Building Houses?

Builder confidence just hit 34, a third of builders are cutting prices, and unsold new-home supply is at post-2008 highs. The only part of the housing market that still worked is shutting down — and that makes the affordability crisis worse, not better.

Paid-members only

Finance Featured

CareDx (CDNA) Jumped 36% as Medicare Ended Its Three-Year Reimbursement War. What's Actually Priced In Before July 30?

Medicare's final LCD affirmed coverage above current utilization — one year after the draft that sank CDNA to $11. The balance-sheet math, the rate fine print bears will grab, and three scenario zones before July 30 earnings.

AI Featured

The Skill Floor for Ransomware Just Collapsed

The first ransomware attack run end-to-end by an AI isn't a novelty — it's a repricing. The marginal cost of a full cyberattack just fell to whatever it costs to run an agent, and cyber insurance, defensive budgets, and federal policy are all still priced as if it didn't happen.

Paid-members only

Markets Featured

Why the World's Best-Performing Stock Market Isn't in Your Index

Nigerian stocks are up more than 50% this year — arguably the world's best return in dollar terms — 29 months after MSCI deleted the market at a price of zero. The gap between the rally and its index invisibility is the trade.

Paid-members only

Finance Featured

Who Gets Crypto When Washington Splits It in Two?

The Senate has three weeks to pass the law that divides crypto between the SEC and the CFTC. After bitcoin's slide from $80,000, almost none of it is priced in — and the biggest winners aren't coins.

Paid-members only

Space Economy Featured

AST SpaceMobile (ASTS) Borrowed Another $1 Billion at Its Cheapest Rate Ever — and the Stock Broke a Four-Month Floor Anyway

ASTS priced $1B of 1.625% converts — its fifth convertible in 18 months — and the stock broke the $63–65 floor that held since April. The fully-loaded share count, the $307M quarterly burn against a $3.6B war chest, the slipped satellite schedule, and three scenario zones.

Paid-members only

Finance Featured

Outlook Therapeutics (OTLK) Faces a Binary FDA Verdict on July 29 — With a Reverse-Split-and-Dilution Vote Stacked in Front of It

OTLK faces a binary July 29 FDA verdict on the first approved ophthalmic bevacizumab for wet AMD after a senior FDA body overruled three rejections — but its confirmatory trial missed its primary endpoint, and a reverse-split-and-dilution vote lands the next day.

Paid-members only

Healthcare Featured

The Law That Lowered Drug Prices Is Quietly Killing the Pill

Medicare's first negotiated prices went live January 1. Buried in the same law is a four-year clock that penalizes cheap oral drugs and rewards expensive biologics — and it's already rerouting where pharma spends its research dollars.

Infrastructure Featured

Why the American West Runs Out of Water Rules This Year

The 2007 rulebook governing the Colorado River expires December 31 with the seven basin states deadlocked. What replaces it — under federal authority, in a drought — will reprice farmland, food, housing, and water rights across the West.

Paid-members only

Finance Featured

Wall Street Turned Songs Into Bonds. Then AI Started Writing Them.

Wall Street securitized song catalogs into a $12.9 billion bond market on the promise of scarce, timeless royalties. Then AI-generated tracks hit 44% of daily uploads — and started diluting the exact pool those bonds are paid from.

Paid-members only

Finance Featured

ASML (ASML) Just Raised Full-Year Guidance by €7 Billion in One Quarter. The Second-Half Ramp Is the Whole Story.

ASML beat on Q2, lifted full-year 2026 guidance to €43–45 billion, and expanded margins — sending the stock toward its all-time high. But the raise implies a €25.9 billion second half, up 43% over H1. The ramp math, the China/export-control read, and four scenario zones.

Finance Featured

America's Invisible Debt Is Getting a Credit Score

For a decade, tens of billions in American BNPL borrowing didn't show up on any credit report. In 2026, FICO's new models and expanded reporting are about to make the phantom debt visible — and reprice consumer risk.

Members only

Markets Featured

Why Did Coffee Just Spike the Most Since 2000?

Arabica just had its wildest day in 26 years — but the real story isn't the weather. It's a market that quietly bet on cheaper coffee, and the frost window that could break the trade.

Paid-members only

Infrastructure Featured

Washington Is Finally Rebuilding the System That Keeps Planes Apart

Congress handed the FAA a $12.5 billion down payment to replace 1980s air traffic control infrastructure. The real trade isn't the radar — it's who captures a decade of recurring spend, and whether Congress funds the rest.

Paid-members only

Finance Featured

Twin Vee (VEEE) Spiked 416% Turning Itself Into a Greenland Minerals Play. The 10% Nobody Is Reading.

A Florida boat builder jumped 416% by reverse-merging into a pre-resource Greenland nickel-copper project. Existing VEEE holders are contracted to end up with 10% — plus a non-transferable trust claim on the boat business. The mechanics, the dilution history, and four scenario zones.